- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00834015
Spinal Fusion and Rehabilitation Study
April 13, 2015 updated by: Arja Häkkinen, Jyväskylä Central Hospital
Outcome of Lumbar Spinal Fusion Patients and Significance of Postoperative Exercise Therapy: Randomized Controlled Trial and Spine Register Study
The aim of the present study is to analyse the significance of postoperative combined strength and aerobic training for outcome of the lumbar fusion patients compared to usual care (patients with isthmic or degenerative spondylolisthesis).
Study Overview
Status
Completed
Detailed Description
Most of the studies published so far about lumbar fusion surgery have been interested in surgical procedure itself or in comparison of conservative or operative treatment.
Less information is available about long-term outcome and exercise programs for operated patients.
Therefore the investigators have developed "Spine fusion register", which include data on surgery procedure and outcome (pain, disability, back muscle function, quality of life, working capacity, reoperations and complications etc.) before and after surgery up to 5 years (started in January 1st, 2008).
The main purpose of the present study is to analyze the significance of 12-month strength and aerobic training for outcome of the lumbar fusion patients compared to usual care.
Patients (N=100) with lumbar fusion because of isthmic or degenerative olisthesis will be will be stratified by catchments area and randomized into combined strength and aerobic training group or into the control group.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jyväskylä, Finland, 40620
- Jyväskylä Central Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- over 20 years old
- isthmic or degenerative spondylolisthesis
Exclusion Criteria:
- cardiovascular or musculoskeletal diseases, which may exclude their ability to perform strength and endurance training and testing
- metabolic bone disease
- psychosocial instability
- malignant disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Experimental
combined strength and aerobic training
|
combined strength and aerobic training group
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain
Time Frame: baseline, 1 year (+ 1 year follow-up)
|
visual analogue scale (VAS)
|
baseline, 1 year (+ 1 year follow-up)
|
|
disability
Time Frame: baseline, 1 year (+ 1 year follow-up)
|
baseline, 1 year (+ 1 year follow-up)
|
|
|
quality of life
Time Frame: baseline, 1 year (+ 1 year follow-up)
|
baseline, 1 year (+ 1 year follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
trunk muscle strength
Time Frame: baseline, 1 year
|
isometric strength of flexor and extensor
|
baseline, 1 year
|
|
spine mobility
Time Frame: baseline, 1 year
|
flexion tests and lateral bending test
|
baseline, 1 year
|
|
fear of movement
Time Frame: baseline, 1 year postoperatively
|
Tampa Scale for Kinesiophobia
|
baseline, 1 year postoperatively
|
|
physical activity
Time Frame: baseline, 1 year
|
International Physical Activity Questionnaire (short form)
|
baseline, 1 year
|
|
depressive symptoms
Time Frame: baseline, 1 year
|
DEPS-scale
|
baseline, 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Arja Häkkinen, Professor, Department of Health Sciences, University of Jyväskylä
- Principal Investigator: Marko Neva, Phd, MD, Tampere University Hospital
- Principal Investigator: Keijo Häkkinen, professor, Department of Biology of Physical Activity, University of Jyväskylä
- Principal Investigator: Joost Dekker, professor, Department of Rehabilitation Medicine, VU University Medical Center, Amsterdam, the Netherlands
- Principal Investigator: Kimmo Vihtonen, Phd, MD, Department of Surgery, University of Tampere
- Principal Investigator: Outi Ilves, Msc, PT, Department of Health Sciences University of Jyvaskyla
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
January 30, 2009
First Submitted That Met QC Criteria
January 30, 2009
First Posted (Estimate)
February 2, 2009
Study Record Updates
Last Update Posted (Estimate)
April 14, 2015
Last Update Submitted That Met QC Criteria
April 13, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ksshp Dnro 4E/2008 (Other Identifier: K-Sshp)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondylolisthesis, Degenerative
-
NuVasiveCompletedDegenerative Disc Disease | Degenerative Scoliosis | Degenerative SpondylolisthesisUnited States
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
NuVasiveCompletedDegenerative Disc Disease | Degenerative Scoliosis | Degenerative SpondylolisthesisUnited States
-
Zimmer BiometCompletedDegenerative Disc Disease | Degenerative SpondylolisthesisUnited States
-
Seton Healthcare FamilyCelling BiosciencesWithdrawnDegenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis | Isthmic-lytic SpondylolisthesisUnited States
-
Lahey ClinicDePuy SynthesCompletedLumbar Spondylolisthesis | Lumbar Spondylosis | Degenerative SpondylolisthesisUnited States
-
Jos M. A. KuijlenRecruitingDegenerative Spondylolisthesis | Spondylolytic SpondylolisthesisNetherlands
-
Mesoblast, Ltd.CompletedSpinal Stenosis | Cervical Degenerative Disc Disease | Degenerative SpondylolisthesisUnited States
-
University of Maryland, BaltimoreWithdrawnDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Lumbar Spinal Stenosis | Degenerative DiseaseUnited States
-
National Taiwan University HospitalCompletedDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Intervertebral Discs | Degenerative Lumbar Spinal StenosisTaiwan
Clinical Trials on Outcome of lumbar spinal fusion patients and significance of postoperative exercise therapy: A randomized controlled trial
-
McGill UniversityFondation Québécoise en Santé RespiratoireCompletedPulmonary Disease, Chronic ObstructiveCanada
-
Hospital General de México Dr. Eduardo LiceagaInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; CCINSHAE... and other collaboratorsTerminated
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico